lactic acid has been researched along with Local Neoplasm Recurrence in 40 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Excerpt | Relevance | Reference |
---|---|---|
" Primary central nervous system lymphoma (PCNSL) is a highly aggressive tumor responsive to high-dose methotrexate based regimens." | 3.73 | Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. ( Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL, 2005) |
"Lactic acid was previously considered a waste product of glycolysis, and has now become a key metabolite for cancer development, maintenance and metastasis." | 1.72 | Lactic Acid Metabolism and Transporter Related Three Genes Predict the Prognosis of Patients with Clear Cell Renal Cell Carcinoma. ( Chen, S; Guo, T; Tang, H; Wang, T; Wang, X; Yuan, Z; Zhang, D; Zhang, J, 2022) |
"Monitoring surgical removal of oral squamous cell carcinomas (OSCC) is being routinely performed through clinical and imaging follow-up." | 1.43 | Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase. ( Biegner, T; Calgéer, B; Grimm, M; Hoefert, S; Kraut, W; Krimmel, M; Munz, A; Reinert, S; Teriete, P, 2016) |
"Oral squamous cell carcinoma (OSCC) is the sixth most common human malignancy." | 1.43 | Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype. ( Dhupar, A; Saluja, TS; Spadigam, A; Syed, S, 2016) |
"Herein, we analyzed biopsies of primary squamous cell carcinoma after surgery and adjuvant irradiation in 17 patients." | 1.43 | Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years. ( Blatt, S; Mueller-Klieser, W; Pabst, AM; Sagheb, K; Schroeder, T; Voelxen, N; Walenta, S; Ziebart, T, 2016) |
"Here, we interrogated head and neck cancer (HNSCC) specimens (n = 12) to examine if different metabolic compartments (oxidative vs." | 1.39 | Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer. ( Ames, JA; Anantharaman, A; Butera, A; Cognetti, DM; Curry, JM; Leiby, B; Lisanti, MP; Martinez-Outschoorn, UE; Sotgia, F; Tuluc, M; Whitaker-Menezes, D, 2013) |
"5-Fluorouracil (5-FU) was suspended in an ethyl acetate solution of poly D,L-lactide-co-glycolic acid (PLGA) and a vacuum drying method was applied." | 1.39 | Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors. ( Chen, Y; Sun, W; Yuan, W, 2013) |
"Neuroblastoma is a common childhood cancer that often results in progressive minimal residual disease after primary tumor resection." | 1.37 | Immunostimulatory sutures that treat local disease recurrence following primary tumor resection. ( Intra, J; Salem, AK; Sandler, AD; Williams, RL; Zhang, XQ; Zhu, X, 2011) |
"Using discriminant analysis, this study found that MR spectroscopy in combination with ADC ratio, rather than ADC value, can improve the ability to differentiate recurrent glioma and radiation injury." | 1.34 | Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. ( Feng, DC; Li, CF; Liu, H; Zeng, QS; Zhen, JH, 2007) |
"Interestingly, also patients with multiple meningiomas show different spectra of their tumors." | 1.34 | MR spectroscopy in patients with intracranial meningiomas. ( Alfke, K; Buhl, R; Hugo, HH; Jansen, O; Mehdorn, HM; Nabavi, A; Wolff, S, 2007) |
"The diagnosis of brain tumors after high-dose radiation therapy is frequently limited by the lack of metabolic discrimination available with conventional imaging methods." | 1.31 | Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. ( Chang, S; Dillon, WP; Graves, EE; Larson, D; McDermott, M; Nelson, SJ; Prados, MD; Verhey, L; Vigneron, DB, 2001) |
"Necrosis was present histologically in four of the five meningiomas classified either as atypical or papillary." | 1.30 | Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. ( Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Nakasu, S; Shino, A, 1999) |
"Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals." | 1.29 | Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.50) | 18.7374 |
1990's | 3 (7.50) | 18.2507 |
2000's | 15 (37.50) | 29.6817 |
2010's | 17 (42.50) | 24.3611 |
2020's | 4 (10.00) | 2.80 |
Authors | Studies |
---|---|
Guo, T | 1 |
Zhang, J | 1 |
Wang, T | 1 |
Yuan, Z | 1 |
Tang, H | 1 |
Zhang, D | 1 |
Chen, S | 1 |
Wang, X | 1 |
Kong, X | 1 |
Feng, M | 1 |
Wu, L | 1 |
He, Y | 1 |
Mao, H | 1 |
Gu, Z | 1 |
Passeri, G | 1 |
Northcote-Smith, J | 1 |
Suntharalingam, K | 1 |
Sushentsev, N | 1 |
Hamm, G | 1 |
Richings, J | 1 |
McLean, MA | 1 |
Menih, IH | 1 |
Ayyappan, V | 1 |
Mills, IG | 1 |
Warren, AY | 1 |
Gnanapragasam, VJ | 1 |
Barry, ST | 1 |
Goodwin, RJA | 1 |
Gallagher, FA | 1 |
Barrett, T | 1 |
Shin, PJ | 1 |
Zhu, Z | 1 |
Camarda, R | 1 |
Bok, RA | 1 |
Zhou, AY | 1 |
Kurhanewicz, J | 1 |
Goga, A | 1 |
Vigneron, DB | 3 |
Nieto, K | 1 |
Pei, P | 1 |
Wang, D | 1 |
Mallery, SR | 1 |
Schwendeman, SP | 1 |
Clendinen, CS | 1 |
Gaul, DA | 1 |
Monge, ME | 1 |
Arnold, RS | 1 |
Edison, AS | 1 |
Petros, JA | 1 |
Fernández, FM | 1 |
Curry, JM | 1 |
Tuluc, M | 1 |
Whitaker-Menezes, D | 1 |
Ames, JA | 1 |
Anantharaman, A | 1 |
Butera, A | 1 |
Leiby, B | 1 |
Cognetti, DM | 1 |
Sotgia, F | 1 |
Lisanti, MP | 1 |
Martinez-Outschoorn, UE | 1 |
Sun, W | 1 |
Chen, Y | 1 |
Yuan, W | 1 |
Clatot, F | 1 |
Gouérant, S | 1 |
Mareschal, S | 1 |
Cornic, M | 1 |
Berghian, A | 1 |
Choussy, O | 1 |
El Ouakif, F | 1 |
François, A | 1 |
Bénard, M | 1 |
Ruminy, P | 1 |
Picquenot, JM | 1 |
Jardin, F | 1 |
Liu, AM | 1 |
Xu, Z | 1 |
Shek, FH | 1 |
Wong, KF | 1 |
Lee, NP | 1 |
Poon, RT | 1 |
Chen, J | 1 |
Luk, JM | 1 |
Draoui, N | 1 |
Schicke, O | 1 |
Seront, E | 1 |
Bouzin, C | 1 |
Sonveaux, P | 1 |
Riant, O | 1 |
Feron, O | 1 |
Deviers, A | 1 |
Ken, S | 1 |
Filleron, T | 1 |
Rowland, B | 1 |
Laruelo, A | 1 |
Catalaa, I | 1 |
Lubrano, V | 1 |
Celsis, P | 1 |
Berry, I | 1 |
Mogicato, G | 1 |
Cohen-Jonathan Moyal, E | 1 |
Laprie, A | 2 |
Bharadwaj, S | 1 |
Venkatraghavan, L | 1 |
Mariappan, R | 1 |
Ebinu, J | 1 |
Meng, Y | 1 |
Khan, O | 1 |
Tung, T | 1 |
Reyhani, S | 1 |
Bernstein, M | 1 |
Zadeh, G | 1 |
Grimm, M | 1 |
Krimmel, M | 1 |
Hoefert, S | 1 |
Kraut, W | 1 |
Calgéer, B | 1 |
Biegner, T | 1 |
Teriete, P | 1 |
Munz, A | 1 |
Reinert, S | 1 |
Saluja, TS | 1 |
Spadigam, A | 1 |
Dhupar, A | 1 |
Syed, S | 1 |
Blatt, S | 1 |
Voelxen, N | 1 |
Sagheb, K | 1 |
Pabst, AM | 1 |
Walenta, S | 2 |
Schroeder, T | 1 |
Mueller-Klieser, W | 2 |
Ziebart, T | 1 |
Intra, J | 1 |
Zhang, XQ | 1 |
Williams, RL | 1 |
Zhu, X | 1 |
Sandler, AD | 1 |
Salem, AK | 1 |
Shaltz, AT | 1 |
Leath, CA | 1 |
Wiedenhoefer, JF | 1 |
Sundborg, MJ | 1 |
Mochizuki, Y | 1 |
Saito, Y | 1 |
Tanaka, T | 1 |
Nitta, N | 1 |
Yamada, H | 1 |
Tsujikawa, T | 1 |
Murata, K | 1 |
Fujiyama, Y | 1 |
Andoh, A | 1 |
Ye, G | 1 |
Zhu, B | 1 |
Yao, Z | 1 |
Yin, P | 1 |
Lu, X | 1 |
Kong, H | 1 |
Fan, F | 1 |
Jiao, B | 1 |
Xu, G | 1 |
Rock, JP | 1 |
Hearshen, D | 1 |
Scarpace, L | 1 |
Croteau, D | 1 |
Gutierrez, J | 1 |
Fisher, JL | 1 |
Rosenblum, ML | 1 |
Mikkelsen, T | 1 |
MOIROUD, P | 1 |
BONNEAU, H | 1 |
Tuggle, DW | 1 |
Mantor, PC | 1 |
Foley, DS | 1 |
Markley, MM | 1 |
Puffinbarger, N | 1 |
Chan, AA | 1 |
Lau, A | 1 |
Pirzkall, A | 2 |
Chang, SM | 1 |
Verhey, LJ | 1 |
Larson, D | 3 |
McDermott, MW | 1 |
Dillon, WP | 3 |
Nelson, SJ | 3 |
Raizer, JJ | 1 |
Koutcher, JA | 1 |
Abrey, LE | 1 |
Panageas, KS | 1 |
DeAngelis, LM | 1 |
Lis, E | 1 |
Xu, S | 1 |
Zakian, KL | 1 |
Chernov, MF | 1 |
Kubo, O | 1 |
Hayashi, M | 1 |
Izawa, M | 1 |
Maruyama, T | 1 |
Usukura, M | 1 |
Ono, Y | 1 |
Hori, T | 1 |
Takakura, K | 1 |
Haas-Kogan, DA | 1 |
Cha, S | 1 |
Banerjee, A | 1 |
Le, TP | 1 |
Lu, Y | 1 |
Nelson, S | 1 |
McKnight, TR | 1 |
Zeng, QS | 1 |
Li, CF | 1 |
Liu, H | 2 |
Zhen, JH | 1 |
Feng, DC | 1 |
Buhl, R | 1 |
Nabavi, A | 1 |
Wolff, S | 1 |
Hugo, HH | 1 |
Alfke, K | 1 |
Jansen, O | 1 |
Mehdorn, HM | 1 |
Sijens, PE | 1 |
Vecht, CJ | 1 |
Levendag, PC | 1 |
van Dijk, P | 1 |
Oudkerk, M | 1 |
Tedeschi, G | 1 |
Lundbom, N | 1 |
Raman, R | 1 |
Bonavita, S | 1 |
Duyn, JH | 1 |
Alger, JR | 1 |
Di Chiro, G | 1 |
Shino, A | 1 |
Nakasu, S | 1 |
Matsuda, M | 1 |
Handa, J | 1 |
Morikawa, S | 1 |
Inubushi, T | 1 |
Graves, EE | 2 |
Chin, C | 1 |
Verhey, L | 2 |
McDermott, M | 2 |
Sneed, PK | 1 |
Chang, S | 2 |
Prados, MD | 2 |
Lamborn, K | 1 |
Ricci, PE | 1 |
Pitt, A | 1 |
Keller, PJ | 1 |
Coons, SW | 1 |
Heiserman, JE | 1 |
Wetterling, M | 1 |
Lehrke, M | 1 |
Schwickert, G | 1 |
Sundfør, K | 1 |
Rofstad, EK | 1 |
Hall, WA | 1 |
Martin, AJ | 1 |
Truwit, CL | 1 |
Sabel, MS | 1 |
Hill, H | 1 |
Jong, YS | 1 |
Mathiowitz, E | 1 |
Bankert, RB | 1 |
Egilmez, NK | 1 |
Morello, E | 1 |
Dernell, WS | 1 |
Kuntz, CA | 1 |
LaRue, SM | 1 |
Lafferty, M | 1 |
Nelson, A | 1 |
Brekke, JH | 1 |
Mallinckrodt, CH | 1 |
Withrow, SJ | 1 |
Manning, MC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies[NCT05145049] | 110 participants (Actual) | Observational [Patient Registry] | 2021-11-01 | Completed | |||
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)[NCT05120284] | Phase 2 | 40 participants (Anticipated) | Interventional | 2022-07-01 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for lactic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Crea | 2014 |
39 other studies available for lactic acid and Local Neoplasm Recurrence
Article | Year |
---|---|
Lactic Acid Metabolism and Transporter Related Three Genes Predict the Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Female; Gene Expression Regulation, Neoplastic; Humans; Ki | 2022 |
Biodegradable gemcitabine-loaded microdevice with sustained local drug delivery and improved tumor recurrence inhibition abilities for postoperative pancreatic tumor treatment.
Topics: Animals; Cell Line, Tumor; Deoxycytidine; Drug Delivery Systems; Gemcitabine; Humans; Lactic Acid; M | 2022 |
Payload Release Profile and Anti-Cancer Stem Cell Properties of Compositionally Different Polymeric Nanoparticles Containing a Copper(II) Complex.
Topics: Breast Neoplasms; Copper; Drug Carriers; Female; Humans; Lactic Acid; Nanoparticles; Neoplasm Recurr | 2023 |
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence.
Topics: Humans; Lactic Acid; Male; Neoplasm Recurrence, Local; Prospective Studies; Prostate; Prostate-Speci | 2023 |
Cancer recurrence monitoring using hyperpolarized [1-
Topics: Animals; Carbon Isotopes; Female; Glycolysis; Humans; Lactic Acid; Magnetic Resonance Imaging; Magne | 2017 |
In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chemoprevention; Delay | 2018 |
Preoperative Metabolic Signatures of Prostate Cancer Recurrence Following Radical Prostatectomy.
Topics: Amino Acids; Big Data; Chromatography, Liquid; Citric Acid Cycle; Glucose; Humans; Lactic Acid; Magn | 2019 |
Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Differentiation; Cell Proliferation; Epithelial Cel | 2013 |
Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Delayed-Action Pr | 2013 |
The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Squamous Cell; Extracellular Matrix; Femal | 2014 |
miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Hepatocellular; Carrier Proteins; Cell P | 2014 |
Antitumor activity of 7-aminocarboxycoumarin derivatives, a new class of potent inhibitors of lactate influx but not efflux.
Topics: Animals; Breast Neoplasms; Colorectal Neoplasms; Coumarins; Female; HCT116 Cells; Humans; Lactic Aci | 2014 |
Serum lactate as a potential biomarker of non-glial brain tumors.
Topics: Biomarkers; Brain Neoplasms; Female; Glycolysis; Humans; Lactic Acid; Male; Neoplasm Recurrence, Loc | 2015 |
Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
Topics: Biomarkers, Tumor; Biopsy; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Immuno | 2016 |
Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Epithelial Cells; Female; Humans; Isoenzymes; L-Lactate Dehyd | 2016 |
Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
Topics: Biomarkers, Tumor; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Head and Neck Neopla | 2016 |
Immunostimulatory sutures that treat local disease recurrence following primary tumor resection.
Topics: Adjuvants, Immunologic; Animals; Biocompatible Materials; Cell Line, Tumor; Delayed-Action Preparati | 2011 |
Reaction to a surgical implant foreign body masquerading as recurrent uterine sarcoma.
Topics: Abdominal Pain; Endometrial Neoplasms; Female; Foreign-Body Reaction; Humans; Lactic Acid; Middle Ag | 2011 |
Endoscopic submucosal dissection combined with the placement of biodegradable stents for recurrent esophageal cancer after chemoradiotherapy.
Topics: Absorbable Implants; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophageal S | 2012 |
Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.
Topics: Aconitic Acid; Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Energy Metabolism; Ethanol | 2012 |
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip | 2002 |
[Excision of a cervical metastasis of an undiscovered spinocellular malpighian epithelioma: absence of recurrence 12 years later, failure to lactate the primary lesion].
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Lactic Acid; Neoplasm Recurrence, Local; | 1955 |
Using a bioabsorbable copolymer plate for chest wall reconstruction.
Topics: Absorbable Implants; Adult; Child; Combined Modality Therapy; Female; Granuloma, Giant Cell; Humans; | 2004 |
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohor | 2004 |
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous Syst | 2005 |
Proton MRS of the peritumoral brain.
Topics: Adult; Aspartic Acid; Biomarkers, Tumor; Brain; Brain Edema; Brain Neoplasms; Epilepsy; Female; Huma | 2005 |
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression | 2005 |
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Diffusion Magn | 2007 |
MR spectroscopy in patients with intracranial meningiomas.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Diagnosis, Differential; Female; Humans; Lactic A | 2007 |
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Follow-Up Studies; Four | 1995 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas | 1997 |
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Biomarkers, Tumor; Brain; Cell Division; Cell Tra | 1999 |
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Choline; Creatine; Female; Glioblastoma; Humans; Lactic Aci | 2000 |
Effect of voxel position on single-voxel MR spectroscopy findings.
Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glio | 2000 |
High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.
Topics: Adenosine Triphosphate; Female; Humans; Lactic Acid; Neoplasm Metastasis; Neoplasm Recurrence, Local | 2000 |
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Energy Metabolism; Female; Follow-Up Studies; | 2001 |
An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Biopsy; Brain; Brain Mapping; Brain Neop | 2001 |
Neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Immunity; Injections, Intralesional; Interleukin-12 | 2001 |
Evaluation of cisplatin in combination with a biologic response modifier in a murine mammary carcinoma model.
Topics: Adenocarcinoma; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bile; Cisplatin; Delayed-Act | 2002 |